ArticleCureus2026

Role of FMS-Like Tyrosine Kinase 3 (FLT3) Inhibitors in a Patient With T/Myeloid Acute Leukemia With an FLT3 Mutation.

Nicholas Elias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.